PMID-sentid Pub_year Sent_text compound_name comp_offset prot_official_name organism prot_offset 30078634-2 2018 However, small-molecule OST inhibitors such as NGI-1 provide a pharmacological approach for regulating N-linked glycosylation. NGI-1 47-52 dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit Homo sapiens 24-27 31511384-9 2019 NGI-1, a small-molecule OST inhibitor, can effectively reduce virus infectivity without affecting cell viability. NGI-1 0-5 dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit Homo sapiens 24-27 31511384-15 2019 NGI-1, a small-molecule inhibitor of OST, also showed a robust inhibitory effect on arenavirus. NGI-1 0-5 dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit Homo sapiens 37-40 29967251-11 2019 CONCLUSIONS: This study suggests that oligosaccharyltransferase inhibition with NGI-1 is a novel approach to radiosensitize malignant gliomas with enhanced RTK signaling.See related commentary by Wahl and Lawrence, p. 455. NGI-1 80-85 ret proto-oncogene Homo sapiens 156-159 29241533-5 2017 Viral mutants adapted to replicate in cells deficient of the OST complex showed resistance to NGI-1 treatment, reinforcing the on-target activity of NGI-1. NGI-1 94-99 dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit Homo sapiens 61-64